Skip to main content

Table 3 Demographic and general clinical characteristics of WNV patients (n = 66)

From: Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients

Gender and age distribution n (%)
Male 42 (63.3)
Female 24 (36.4)
Total 66
Age (average) 56.74 years
Age (median) 60.0 years
patients below 65 years old 43 (64.15)
- patients < 45 years old 19 (28.79)
- patients 45-65 years old 24 (36.4)
patients over 65 years old 23 (34.8)
Time between onset of neurological symptoms and hospital admission (days)
 average 6.01
 median 4.00
Number of Comorbidities n (%)
 None or 1 illness 37 (56.1)
 2 or more illnesses 29 (43.9)
Relevant medication n (%)
 None 59 (89.3)
 Immunsuppressive therapy 4(6.1)
 Active antitumor therapy 1 (1.5)
 Steroid therapy 1 (1.5)
 Data not available (NA) 1 (1.5)
General symptoms at presentation n (%)
 Fever 61 (92.42)
 Weakness and malaise 26 (39.4)
 Nausea, vomiting 26 (39.4)
 Skin rash 20 (30.3)
 Diarrhea 7 (10.6)
 Muscle/joint pain 7 (10.6)
 Abdominal pain 5 (7.6)
 Coughing, upper respiratory tract symptom 5 (7.6)